PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of arthresbiomed central web sitesearch.manuscript submission.see also journal with issn 1478-6354registration.reference to the article.journal front page.
 
Arthritis Res. 2000; 2(6): 429–432.
Published online 2000 August 17. doi:  10.1186/ar122
PMCID: PMC128869
Insights into rheumatoid arthritis derived from the Sa immune system
Henri A Ménard,1 Elvy Lapointe,1 Moulay D Rochdi,1 and Zhi J Zhou1
1Université de Sherbrooke, Sherbrooke (Quebec), Canada
Henri A Ménard: henri.a.menard/at/muhc.mcgil.ca
Received June 12, 2000; Revisions requested June 27, 2000; Revised July 25, 2000; Accepted July 28, 2000.
Abstract
The Sa system is a recently described immune system that has a specificity and positive predictive value of nearly 100% for rheumatoid arthritis (RA) in Asia, Europe and the Americas. Its sensitivity of 30-40% suggests that it identifies a subset of RA patients. Anti-Sa antibodies are present from disease onset and are predictive of disease severity. The immune reactants are plentiful in the target tissue: antigen is present in the synovium, IgG antibody in the fluid. Immunologically, Sa is a hapten-carrier antigen in which vimentin is the carrier and citrulline is the hapten. The citrullination of vimentin is closely related to apoptosis, and citrullinated vimentin is extremely sensitive to digestion by the ubiquitous calpains. Nevertheless, Sa is found in only a few cell lines. Calpastatin, the natural specific inhibitor of calpains, is also a RA-associated, albeit non-specific, autoimmune system. Is it possible that calpain-related apoptotic pathways could be prominent in cells containing Sa? The task is to reconcile the specificity of Sa/citrullinated proteins in a multifactorial and polygenic disease such as RA.
Keywords: anti-Sa autoantibodies, citrullinated proteins, diagnosis, prognosis, rheumatoid arthritis
Articles from Arthritis Research are provided here courtesy of
BioMed Central